Optimizing adalimumab treatment in psoriasis with concomitant methotrexate: a randomized controlled trial

被引：0
|
作者：
Van der Kraaij, G. [1 ,2 ]
Busard, C. [1 ]
van den Reek, J. [3 ]
Menting, S. [1 ]
de Jong, E. [3 ,4 ]
de Kort, W. [5 ]
Lambert, J. [6 ]
Spuls, P. [1 ,2 ]
机构：
[1] Amsterdam UMC, Dermatol, Amsterdam, Netherlands
[2] Amsterdam UMC, Publ Hlth, Amsterdam, Netherlands
[3] Radboud UMC, Dermatol, Nijmegen, Netherlands
[4] Univ Nijmegen, Nijmegen, Netherlands
[5] Amphia Ziekenhuis, Dermatol, Breda, Netherlands
[6] UZ Gent, Dermatol, Ghent, Belgium
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷
关键词：
Adalimumab; Drug survival; Psoriasis; ANTIBODY;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P043
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [1] Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
    Busard, Celine
    Menting, Stef
    van Bezooijen, Sun-Jine
    van den Reek, Juul
    Hutten, Barbara
    Prens, Errol
    de Jong, Elke
    van Doorn, Martijn
    Spuls, Phyllis
    TRIALS, 2017, 18
  • [2] Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
    C. I. Busard
    S. P. Menting
    J. S. van Bezooijen
    J. M. van den Reek
    B. A. Hutten
    E. P. Prens
    E. M. de Jong
    M. B. van Doorn
    P. I. Spuls
    Trials, 18
  • [3] Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
    Celine Busard
    Stef Menting
    SJ van Bezooijen
    Juul van den Reek
    Barbara Hutten
    Errol Prens
    Elke de Jong
    Martijn van Doorn
    Phyllis Spuls
    Trials, 18
  • [4] A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis
    Bigby, M
    ARCHIVES OF DERMATOLOGY, 2004, 140 (03) : 347 - 348
  • [5] Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)
    Busard, Celine
    Menting, Stef
    van Bezooijen, S. J.
    van den Reek, Juul
    Hutten, Barbara
    Prens, Errol
    de Jong, Elke
    van Doorn, Martijn
    Spuls, Phyllis
    TRIALS, 2017, 18
  • [6] Comparison of treatment for psoriasis with methotrexate and adalimumab
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (03) : e64 - e64
  • [7] Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies
    Yang, Xiaolin
    Liu, Yan
    MEDICINE, 2024, 103 (32)
  • [8] Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial
    van der Kraaij, Gayle
    Busard, Celine
    van den Reek, Juul
    Menting, Stef
    Musters, Annelie
    Hutten, Barbara
    de Rie, Menno
    Ouwerkerk, Wouter
    Van Bezooijen, Sun-Jine
    Prens, Errol
    Rispens, Theo
    de Vries, Annick
    de Jong, Elke
    de Kort, Wim
    Lambert, Jo
    van Doorn, Martijn
    Spuls, Phyllis
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (09) : 2375 - +
  • [9] Optimizing Secukinumab Treatment in Psoriasis with Concomitant Methotrexate Administration: Minireview and A Case Report
    Kostaki, Dimitra
    Aquila, Emilia
    Macaluso, Laura
    Mattozzi, Carlo
    Richetta, Antonio Giovanni
    CASE REPORTS IN DERMATOLOGY, 2019, 11 : 17 - 22
  • [10] Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis
    Prussick, Ronald
    Unnebrink, Kristina
    Valdecantos, Wendell C.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (08) : 864 - 868
12345